FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048846693> ?p ?o ?g. }

• W3048846693 abstract "Expansion of the novel human respiratory coronavirus (SARS-CoV-2) is a global public health emer-gency concern. There is no known successful treatment as of this time and there is a need for medical options to mitigate this current epidemic. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) receptor and is primarily trophic for the lower and upper respiratory tract. A number of current studies on COVID-19 demonstrates the substantial increase in pro-inflammatory factors in the lungs during infection. The virus is also documented in the central nervous system and, in particular, in the brainstem, which plays a key role in respiratory and cardiovascular function. Currently, there are few antiviral approaches, and several alternative drugs are under investigation. Two of these are Idelalisib and Ebastine, already proposed as preventive strategies in airways and al-lergic diseases. The interesting and evolving potentiality of phosphoinositide 3-kinase δ (PI3K in-hibitors, together with Ebastine, lies in their ability to suppress the release of pro-inflammatory cyto-kines, such as IL-1, IL-8, IL-6 and TNF, by T-cells. This may represent an optional therapeutic choice for COVID-19 to reduce inflammatory reactions and mortality, enabling patients to recover faster. This concise communication aims to provide new potential therapeutic targets capable of mitigating and alleviating SARS-CoV-2 pandemic infection." @default.
• W3048846693 created "2020-08-18" @default.
• W3048846693 creator A5008128839 @default.
• W3048846693 creator A5022738331 @default.
• W3048846693 creator A5026956525 @default.
• W3048846693 creator A5035669120 @default.
• W3048846693 creator A5056803476 @default.
• W3048846693 creator A5064994916 @default.
• W3048846693 creator A5072510276 @default.
• W3048846693 creator A5077567990 @default.
• W3048846693 creator A5084151674 @default.
• W3048846693 creator A5086641754 @default.
• W3048846693 creator A5088969006 @default.
• W3048846693 date "2020-08-21" @default.
• W3048846693 modified "2023-09-28" @default.
• W3048846693 title "PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19" @default.
• W3048846693 cites W1135839845 @default.
• W3048846693 cites W1917160907 @default.
• W3048846693 cites W1964841658 @default.
• W3048846693 cites W1966238900 @default.
• W3048846693 cites W2000040025 @default.
• W3048846693 cites W2011500810 @default.
• W3048846693 cites W2021442163 @default.
• W3048846693 cites W2028521865 @default.
• W3048846693 cites W2028549997 @default.
• W3048846693 cites W2034623756 @default.
• W3048846693 cites W2036355708 @default.
• W3048846693 cites W2039533506 @default.
• W3048846693 cites W2070361307 @default.
• W3048846693 cites W2070463916 @default.
• W3048846693 cites W2072765132 @default.
• W3048846693 cites W2097637220 @default.
• W3048846693 cites W2106687085 @default.
• W3048846693 cites W2152329221 @default.
• W3048846693 cites W2282773014 @default.
• W3048846693 cites W2338396143 @default.
• W3048846693 cites W2615467479 @default.
• W3048846693 cites W2620389084 @default.
• W3048846693 cites W2766931063 @default.
• W3048846693 cites W2790687399 @default.
• W3048846693 cites W2884622213 @default.
• W3048846693 cites W2891482452 @default.
• W3048846693 cites W2902094068 @default.
• W3048846693 cites W2917639850 @default.
• W3048846693 cites W2935641416 @default.
• W3048846693 cites W3001118548 @default.
• W3048846693 cites W3001456238 @default.
• W3048846693 cites W3001638293 @default.
• W3048846693 cites W3001897055 @default.
• W3048846693 cites W3003217347 @default.
• W3048846693 cites W3004280078 @default.
• W3048846693 cites W3004919484 @default.
• W3048846693 cites W3006390878 @default.
• W3048846693 cites W3008090866 @default.
• W3048846693 cites W3008827533 @default.
• W3048846693 cites W3009799538 @default.
• W3048846693 cites W3009859788 @default.
• W3048846693 cites W3009976289 @default.
• W3048846693 cites W3010580363 @default.
• W3048846693 cites W3011176674 @default.
• W3048846693 cites W3011871622 @default.
• W3048846693 cites W3011976215 @default.
• W3048846693 cites W3012405893 @default.
• W3048846693 cites W3012492786 @default.
• W3048846693 cites W3012655019 @default.
• W3048846693 cites W3013086033 @default.
• W3048846693 cites W3013442544 @default.
• W3048846693 cites W3015190630 @default.
• W3048846693 cites W3015826289 @default.
• W3048846693 cites W3016722483 @default.
• W3048846693 cites W3016852213 @default.
• W3048846693 cites W3017440151 @default.
• W3048846693 cites W3020375197 @default.
• W3048846693 cites W3022534749 @default.
• W3048846693 cites W3022878099 @default.
• W3048846693 cites W3022998931 @default.
• W3048846693 cites W3023140107 @default.
• W3048846693 cites W3023674098 @default.
• W3048846693 cites W3024355918 @default.
• W3048846693 cites W3024521558 @default.
• W3048846693 cites W3024638242 @default.
• W3048846693 cites W3025283885 @default.
• W3048846693 cites W3026376146 @default.
• W3048846693 cites W3031365196 @default.
• W3048846693 cites W3032902005 @default.
• W3048846693 cites W3032937492 @default.
• W3048846693 cites W3033448316 @default.
• W3048846693 cites W3034537415 @default.
• W3048846693 cites W3039789179 @default.
• W3048846693 cites W3040394931 @default.
• W3048846693 cites W3040519011 @default.
• W3048846693 cites W3104452157 @default.
• W3048846693 doi "https://doi.org/10.3389/fimmu.2020.02094" @default.
• W3048846693 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7472874" @default.
• W3048846693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32973818" @default.
• W3048846693 hasPublicationYear "2020" @default.
• W3048846693 type Work @default.
• W3048846693 sameAs 3048846693 @default.
• W3048846693 citedByCount "23" @default.
• W3048846693 countsByYear W30488466932021 @default.

• next